Track topics on Twitter Track topics that are important to you
Defymed is a spin -off of the “Centre Europeen d’etude du Diabete” (CeeD) which has been working on the conception of a bio-artificial pancreas since 1996.
This work was carried out in tight collaboration with the “Centre de Transfert de Technologie du Mans” (CTTM) and STATICE in the frame of two research European programs: FP4 (1996-2000) and FP6 (2004-2007). This work has led to the development of a prototype of MAILPAN® medical device.
The bioartificial pancreas is believed to be the most physiological solution under development, and the one that could bring the ideal autonomy to Type 1 diabetic patients.
The strategy of encapsulation involves placing insulin-secretory cells within semi-permeable devices made of friendly and biocompatible materials. This kind of device should allow the passage of small molecules such as insulin and glucose but prevent the entry of molecules of the immune system that could kill the encapslated cells. Thus, encapsulating these cells should prevent allograft rejection and autoimmune reaction.
Centre Européen Étude du Diabète C.E.E.D.
Boulevard René Leriche
Phone: +33 (0)3 90 20 12 12
French-based Medtech company Defymed confirms its global position. Recognized by its peers for the development of two innovative medical devices - ExOlin®, an insulin delivery de...
Defymed is a spin -off of the “Centre Europeen d’etude du Diabete” (CeeD) which has been working on the conception of a bio-artificial pancreas since 1996. This work was ca...
We have published hundreds of Defymed news stories on BioPortfolio along with dozens of Defymed Clinical Trials and PubMed Articles about Defymed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Defymed Companies in our database. You can also find out about relevant Defymed Drugs and Medications on this site too.
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...